OSAP.Q Stock Overview
Operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
ProSomnus, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.028 |
| 52 Week High | US$5.00 |
| 52 Week Low | US$0.008 |
| Beta | 0.60 |
| 1 Month Change | -82.42% |
| 3 Month Change | -94.72% |
| 1 Year Change | -99.44% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.71% |
Recent News & Updates
Shareholder Returns
| OSAP.Q | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -37.7% | -2.1% | -0.9% |
| 1Y | -99.4% | 4.3% | 25.8% |
Return vs Industry: OSAP.Q underperformed the US Medical Equipment industry which returned 4.3% over the past year.
Return vs Market: OSAP.Q underperformed the US Market which returned 25.8% over the past year.
Price Volatility
| OSAP.Q volatility | |
|---|---|
| OSAP.Q Average Weekly Movement | 52.0% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: OSAP.Q's share price has been volatile over the past 3 months.
Volatility Over Time: OSAP.Q's weekly volatility has increased from 31% to 52% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 136 | Len Liptak | www.prosomnus.com |
ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.
ProSomnus, Inc. Fundamentals Summary
| OSAP.Q fundamental statistics | |
|---|---|
| Market cap | US$586.18k |
| Earnings (TTM) | -US$13.76m |
| Revenue (TTM) | US$29.30m |
0.0x
P/S Ratio0.0x
P/E RatioIs OSAP.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSAP.Q income statement (TTM) | |
|---|---|
| Revenue | US$29.30m |
| Cost of Revenue | US$14.72m |
| Gross Profit | US$14.58m |
| Other Expenses | US$28.35m |
| Earnings | -US$13.76m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.79 |
| Gross Margin | 49.77% |
| Net Profit Margin | -46.97% |
| Debt/Equity Ratio | -120.7% |
How did OSAP.Q perform over the long term?
See historical performance and comparison